ATRC Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - AtriCure Inc - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 22.61 USD -1.91%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast ATRC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ATRC is 57.27 USD with a low forecast of 42.42 USD and a high forecast of 68.25 USD.

ATRC Lowest Forecast

Wall Street Target

ATRC Average Forecast

Wall Street Target

ATRC Highest Forecast

Wall Street Target

88% Upside

153% Upside

202% Upside

The latest public price target was made on Apr 23, 2024 by Suraj Kalia from Oppenheimer , who expects ATRC stock to rise by 42% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst	Price Target	Date	Article
Suraj Kalia Oppenheimer	32 USD Upside 42%	3 days ago Apr 23, 2024	Oppenheimer Upgrades AtriCure Inc. (ATRC) to Outperform StreetInsider
Unknown Analyst Canaccord Genuity	81 USD Upside 258%	1 year ago Feb 6, 2023	Canaccord Genuity Maintains Buy on AtriCure, Raises Price Target to $81 Benzinga

Price Target	32 USD
Upside/Downside	42%

Price Target	81 USD
Upside/Downside	258%

Apex Biotechnology Corp

127% Upside

Pro-Dex Inc

49% Upside

Fukuda Denshi Co Ltd

29% Downside

Lutronic Corp

10% Downside

Apex Biotechnology Corp

127% Upside

Pro-Dex Inc

49% Upside

Fukuda Denshi Co Ltd

29% Downside

Lutronic Corp

10% Downside

Beijing Wandong Medical Technology Co Ltd

8% Downside

Xiangyu Medical Co Ltd

51% Upside

iRay Technology Co Ltd

63% Upside

Double Medical Technology Inc

56% Upside

Revenue
Forecast

For the last 8 years the compound annual growth rate for AtriCure Inc's revenue is 15%. The projected CAGR for the next 3 years is 15%.

15%

15%

-2%

What are analyst estimates?

Operating Income
Forecast

N/A

N/A

-9%

What are analyst estimates?

Net Income
Forecast

N/A

N/A

-23%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for ATRC is 57.27 USD with a low forecast of 42.42 USD and a high forecast of 68.25 USD.

For the last 8 years the compound annual growth rate for AtriCure Inc's revenue is 15%. The projected CAGR for the next 3 years is 15%.

Join more than 131,600+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.